CD8A and neoplasm: Obviously, various anti-tumor immune-related functions such as DC function and antigen presentation, CD8+ T and NK cell function, interferon response, and cytokines were more potent in patients with low TANRS compared to those with high TANRS, indicating an association between low-TANRS and enhanced anti-tumor immunity (Figure 7E). Next, the differential expression of immunomodulatory molecules was analyzed.